Hypocoagulability, hypercoagulability and the interpretation of 'normal' kaolin-activated thrombelastographs in the perioperative period

Anaesthesia and Intensive Care

Volumn 39, Issue 5, 2011, Pages 802-803

  Gibbs, N M ^a  

^a SIR CHARLES GAIRDNER HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BATROXOBIN; BLOOD CLOTTING FACTOR 13; CLOPIDOGREL; KAOLIN; THROMBIN; THROMBOPLASTIN;

BLOOD VESSEL INJURY; CLINICAL EFFECTIVENESS; DIAGNOSTIC ACCURACY; DRUG EFFECT; EDITORIAL; HYPERCOAGULABILITY; HYPOCOAGULABILITY; IN VIVO STUDY; PERIOPERATIVE PERIOD; PROTHROMBIN TIME; THROMBOELASTOGRAPHY;

EID: 80052985835     PISSN: 0310057X     EISSN: 14480271     Source Type: Journal    
DOI: 10.1177/0310057x1103900504     Document Type: Editorial

References (7)

1. Weinberg L, Scurrah N, Parker FC, Dauer R, Marshall J, McCall P et al. Markers of coagulation activation after hepatic resection for cancer: evidence of sustained upregulation of coagulation. Anaesth Intensive Care 2011; 39:5:847-853.
2. Hoffman M, Monroe DM. A cell-based model of hemostasis. Thromb Hemost 2001; 85:958-965. (Pubitemid 32573743)
3. Ng VL. Prothrombin time and partial thromboplastin time assay considerations. Clin Lab Med 2009; 29:253-263.
4. Gibbs NM. Point of care assessment of antiplaelet agents in the perioperative period: a review. Anaesth Intensive Care 2009; 37:354-369.
5. Craft RM, Chavez JJ, Bresee SJ, Wortham DC, Cohen E, Carroll RC. A novel modification of the thrombelastograph assay, isolating platelet function, correlates well with platelet aggregation. J Lab Clin Med 2004; 143:301-309. (Pubitemid 38586495)
6. Mallett SV, Cox DJ. Thrombelastography. Br J Anaesth 1992; 69:307-313.
7. Gibbs NM. Postoperative hypercoagulability: Mechanisms and clinical implications. In: Keneally J, Jones M, eds. Australasian Anaesthesia 1994. Melbourne: Australian and New Zealand College of Anaesthetists 1994.